Oklahoma has signed Senate Bill 933 (SB 933) into law, known as the Right to Try for Individualized Treatments Act, allowing eligible patients to request investigational treatments not yet widely available. The law aims to provide more options for individuals facing serious medical conditions who have exhausted traditional treatments.
Senator Brenda Stanley emphasized the importance of the legislation, saying, “This legislation is about giving hope to patients and families who may have exhausted all traditional treatment options. Oklahomans deserve the opportunity to pursue innovative, individualized care in consultation with their doctors, without unnecessary red tape.”
Key Provisions of SB 933
The Right to Try law includes several significant provisions:
- Eligibility: Patients can request individualized investigational treatments from authorized facilities.
- Voluntary Participation: Health plans, hospitals, and governmental agencies are not required to provide or pay for treatments; coverage remains at their discretion.
- Liability Protections: Manufacturers and licensed health care providers are protected from legal liability associated with providing investigational treatments.
- Clinical Trials: The law does not expand mandatory coverage requirements for clinical trial participation.
The legislation is designed to support medical freedom while ensuring patients can pursue promising treatments in consultation with their doctors.
Implementation and Effective Date
SB 933 will go into effect on November 1, 2026, allowing eligible patients across Oklahoma to begin accessing individualized investigational treatments under the new framework.
Senator Stanley highlighted the patient-centered approach, stating, “Patients facing difficult diagnoses should have every possible opportunity to pursue promising treatment options. This law helps ensure Oklahoma supports medical freedom, innovation, and compassionate care.”
Table: Overview of Oklahoma SB 933
| Category | Details |
|---|---|
| Bill Number | Senate Bill 933 (SB 933) |
| Law Name | Right to Try for Individualized Treatments Act |
| Purpose | Expand access to investigational treatments for eligible patients |
| Patient Eligibility | Individuals who have exhausted traditional treatment options |
| Coverage Requirement | Voluntary for insurers and government agencies |
| Liability Protections | Treatment manufacturers and licensed healthcare providers |
| Clinical Trial Impact | No expansion of mandatory coverage requirements |
| Effective Date | November 1, 2026 |
| Key Supporter | Senator Brenda Stanley |
Implications for Patients
The new law provides a pathway for Oklahomans to pursue innovative treatments that may not yet be available through standard channels or clinical trials.
While coverage is voluntary, patients now have legal authority to request individualized investigational therapies from participating facilities, enhancing access to potential life-saving or life-extending care.
Oklahoma’s SB 933 establishes a legal framework for patients to access investigational treatments while balancing provider protections and voluntary coverage.
By supporting medical innovation and patient choice, the law aims to provide hope for individuals facing serious health conditions and strengthen compassionate care options across the state.
